BioCentury
ARTICLE | Company News

Immusol, Medarex deal

February 26, 2001 8:00 AM UTC

The companies will develop human antibody therapeutics using MEDX's UltiMAb Human Antibody Development System and therapeutic targets discovered using Immusol's Inverse Genomics platform. The partners...